Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment.

Sci Rep · 2023 · PMC10507096 · PMID 37723192

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

borderline significantp = 0.059so close (0.05 < p ≤ 0.1)

For Tier I/II alterations, we observed a modified PFS ratio (PFS targeted /PFS pre-chemotherapy ) of 1.86 that was borderline significant (p = 0.059) (Fig. 4 C).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.